Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2026-02-19 @ 2:47 AM
Study NCT ID:
NCT02319369
Status:
TERMINATED
Last Update Posted:
2021-10-11
First Post:
2014-12-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Sponsor:
Daiichi Sankyo
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-25
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-21
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-15
First Submit QC Date:
None
Study First Post Date:
2014-12-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-04
Results First Submit QC Date:
None
Results First Post Date:
2021-10-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-14
Last Update Post Date:
2021-10-11
Last Update Post Date Type:
ACTUAL